@FierceBiotech: Amgen scores PhIII success with BioVex virus against melanoma. More | Follow @FierceBiotech
@JohnCFierce: AstraZeneca feels sting of union backlash against R&D upheaval. Story | Follow @JohnCFierce
@RyanMFierce: Merck slashes data-management costs with China site. Article | Follow @RyanMFierce
> Former Pfizer ($PFE) R&D chief John LaMattina has been hired to advise the U.K.'s Ziarco, which is working on new drugs for inflammatory and allergic diseases. Story
> Merrion Pharmaceuticals says that its partner, Novo Nordisk ($NVO), successfully completed a single dose Phase I trial with a novel oral insulin, NN1954. Merrion Pharmaceuticals GIPET Technology was used in the formulation. Release
> Merck Serono has struck a strategic alliance with Nordic Bioscience Clinical Development A/S on Merck Serono's investigational drug sprifermin--recombinant human FGF-18--in osteoarthritis. Release
> Lundbeck and Teva ($TEVA) announced that a study of Azilect (rasagiline tablets) for early Parkinson's met its primary endpoint. Release
> Bothell, WA-based Alder dosed the first patients in their Phase II study of an experimental migraine treatment, ALD403. Release
Pharma News
@FiercePharma: Krystexxa sales still aren't taking off. Savient says Q4 sales of gout drug only up to $4.7M from $3M. Report | Follow @FiercePharma
@EricPFierce: Italy's the 2nd largest API maker behind China, says Italian expert. Who would have guessed it? India is 3rd. More | Follow @EricPFierce
> Valeant nabs skin-care specialist Obagi for $344M. News
> Merck KGaA, Bristol-Myers plan joint assault on China's diabetes market. More
> Reuters: Roche jumps into bidding for lab equipment maker Life Tech. Story
@FierceMedDev: Post-PMA, Cardiovascular Systems pursues public offering. More | Follow @FierceMedDev
@MarkHFierce: Spurned by Illumina, Roche may have found a new gene sequencer/Dx company to love. But at what price? Story | Follow @MarkHFierce
@DamianFierce: With election long passed, device tax lobbyists ply Dems. Article | Follow @DamianFierce
> Sorin eyes FDA approval with heart device trial. Article
> SynCardia snags $19M for artificial heart. Report
Biomarkers News
> Luminex to collaborate with Merck on Alzheimer's biomarker diagnostic. Report
> Mount Sinai wins $5M to study vocal disorder biomarkers. Item
> Pee in a cup to diagnose gastroesophageal cancer. More
> GenoMine test spots three new kidney cancer biomarkers. Article
> Texas research team spots Barrett's esophagus biomarkers. Story
Drug Delivery News
@MichaelGFierce: Spectrum picks up orphan cancer drug with stabilized delivery. More | Follow @MichaelGFierce
> New nanomed reduces inflammation in injured tissue by natural means. Story
> Delivery gel releases drugs in response to pressure. More
> Shire bets on PhII protein-delivery therapy to fight infant blindness. Article
> Needle-free ear infection patch delivers bacteria-killing vaccine. Item
And Finally…Investigators at Wake Forest Baptist have developed a "toxicity map" to help guide surgeons treating brain cancer. Release